Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Chinese Patent Office
Accenture
Fuji
Federal Trade Commission
Merck
McKinsey
Cipla
Argus Health

Generated: December 16, 2018

DrugPatentWatch Database Preview

Litigation for NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE

« Back to Dashboard

US Court Litigation for NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
5,037,845 ➤ Sign Up ➤ Sign Up 2006-09-08 2009-06-23 35:271 Patent Infringement District Court, D. Delaware None ➤ Sign Up
5,872,145 ➤ Sign Up ➤ Sign Up 2008-11-14 2011-08-05 35:271 Patent Infringement District Court, E.D. Texas None ➤ Sign Up
5,872,145 ➤ Sign Up ➤ Sign Up 2008-11-14 2011-08-05 35:271 Patent Infringement District Court, E.D. Texas None ➤ Sign Up
6,060,499 ➤ Sign Up ➤ Sign Up 2008-11-14 2011-08-05 35:271 Patent Infringement District Court, E.D. Texas None ➤ Sign Up
6,060,499 ➤ Sign Up ➤ Sign Up 2008-11-14 2011-08-05 35:271 Patent Infringement District Court, E.D. Texas None ➤ Sign Up
Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Patent Trial and Appeal Board Cases for NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
7,332,183 Graybar Pharmaceuticals, LLC ➤ Sign Up 2015-11-12 2015-11-12 POZEN Inc. Inter partes review ➤ Sign Up 2016-05-06 John Plachetka ➤ Sign Up
Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
UBS
Daiichi Sankyo
Accenture
Fuji
Federal Trade Commission
Citi
Chinese Patent Office
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.